The Oregon State Pharmacy Association announced the results of its PBM study conducted by 3 Axis Advisors to review reimbursement trends between payers and retail pharmacies between 2019 and 2021.

Also in Oregon, the Board of Pharmacy posted its agenda for its Strategic Planning Meeting scheduled to be held on November 10.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted the agenda and meeting materials for its October 12-14 meeting.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority announced Nevada has jointed Oregon and Washington to offer the ArrayRx Card, a prescription discount card, formerly referred to as the Oregon/Washington Prescription Discount Card.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted the agenda for the Public Health & Pharmacy Formulary Advisory Committee to be held on September 21. Please note agenda items related to protocol development and proposed protocol revisions.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority’s Immunization Policy Advisory Team (IPACT) will meet September 1 via Zoom. To register in advance for this meeting, use this link.  

Also in Oregon, the Oregon Health Authority released its 2021 Coordinated Care Organization (COO) Metrics Report. Although statewide performance showed improvement on most of the 14 incentive measures, the exceptions were two immunization measures related to youth immunizations which were down 7.7% for adolescents and 8.3% for immunizations received by the child’s second birthday. These continue to be affected by the disruptions in preventive care that occurred during the pandemic. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy issued a Public Meeting Notice and published the agenda and meeting materials for its next meeting to be held August 10-12, 2022.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon State Newsletter – June 2022 has been posted to the NABP/Oregon website and includes the following information. 

• No. 678 Safe Pharmacy Practice Conditions 
• No. 679 Expedited Partner Therapy Updates 
• No. 680 Rulemaking
• Rule Feedback 
• Permanent Rules Adopted in April 2022
• Permanent Rules Adopted in June 2022
• No. 681 Compliance: Legal Advice vs Legal Information 
• No. 682 Licensing: Technician Renewals Due June 30, 2022 
• No. 683 REALD and Pharmacies 

Also in Oregon, the Board of Pharmacy adopted the following temporary rules effective July 1, 2022, through December 27, 2022. 

• OAR 855-019-0210 related to Duties of Pharmacist Receiving a Prescription  
• OAR 855-139-0699 related to a Retail Drug Outlet RDSP (Remote Dispensing Site Pharmacy) 

Also in Oregon, the Board of Pharmacy adopted the following permanent rules at the June 2022 Board Meeting. 

• Divisions 006/041/043/045/080/139 – related to Standards Adopted by Reference & Definitions  - Effective June 16, 2022 
• Divisions 019/025/041 – related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification - Effective June 16, 2022
• Divisions 019/041/139 – related to Interpreters  – Effective September 1, 2022 
• Divisions 019/143 – related to Pharmacy Prescription Lockers - Effective June 16, 2022 
• Division 020 – related to Pharmacist Prescriptive Authority – Tobacco Cessation & PrEP - Effective June 16, 2022 
• Division 031 – related to Public Health Emergency Sunset – Effective June 16, 2022 
• Division 041 – related to Telework – Effective June 16, 2022
• Divisions 041/139 – related to Permanent Pharmacy Closure Requirements – Effective June 16, 2022 
• Division 080 – related to Pseudoephedrine/Ephedrine & Interns – Effective June 16, 2022 
• Division 110 – related to Drug Outlet Categories – Effective June 16, 2022 
• Division 139 – related to RDSP [Remote Dispensing Site Pharmacies] – Effective June 16, 2022 

Finally in Oregon, effective July 1, 2022, through December 27, 2022, the Oregon Health Authority adopted a temporary rule amending OAR 410-121-0030 and 410-121-0040 in accordance with the Drug Use Review (DUR) Pharmacy & Therapeutics (P&T) Committee’s recommendations made during the June 2, 2022 meeting.   

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted a public notice and agenda for the Safe Pharmacy Practice Conditions Workgroup meeting scheduled for July 18.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted the June 8-10, 2022 Board Meeting agenda and meeting materials.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.